Skip to Content
Abbott Laboratories leveled up on this year’s Fortune 500 list, leaping from last year’s rank of 104 to No. 89. Why? COVID testing. Abbott was one of the first to jump into the testing market, and that alacrity has paid off; the company’s diagnostics unit, which also houses its COVID test arm, raked in more than $4 billion in sales during the first quarter of 2021 alone. Abbott, though, isn’t putting all its eggs in one basket. As life starts returning to normal, the company believes its diabetes care and glucose monitoring products will continue to fuel growth.
Lists ranking Abbott Laboratories
RANK350
Global 500 - 2021Total revenue for the world’s biggest companies fe...READ MOREview in list
RANK89
Fortune 500 - 2021This year’s Fortune 500 marks the 67th running of ...READ MOREview in list
RANK20
28 Best Large Workplaces in Health Care - 2021The best U.S. health care companies with more than...READ MOREview in list
RANK42
World’s Most Admired Companies - 2021After a year in which humanity leaned more heavily...READ MOREview in list
RANK24
Change the World - 2020As we face unprecedented collective challenges, co...READ MOREview in list